{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,31]],"date-time":"2026-03-31T15:06:36Z","timestamp":1774969596765,"version":"3.50.1"},"reference-count":31,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"vor","delay-in-days":365,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Transplantation and Cellular Therapy"],"published-print":{"date-parts":[[2024,3]]},"DOI":"10.1016\/j.jtct.2023.12.011","type":"journal-article","created":{"date-parts":[[2023,12,22]],"date-time":"2023-12-22T22:42:49Z","timestamp":1703284969000},"page":"285-297","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":12,"title":["Efficacy of Multiple SARS-CoV-2 Vaccine Doses in Patients with B Cell Hematologic Malignancies Receiving Chimeric Antigen Receptor T Cell Therapy: A Contemporary Cohort Analysis"],"prefix":"10.1016","volume":"30","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1128-0445","authenticated-orcid":false,"given":"Muhammad Bilal","family":"Abid","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3422-7989","authenticated-orcid":false,"given":"Micah","family":"Rubin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8129-0614","authenticated-orcid":false,"given":"Aniko","family":"Szabo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Walter","family":"Longo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Timothy S.","family":"Fenske","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cole","family":"McCoy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aaron","family":"Lorge","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sameem","family":"Abedin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anita","family":"D'Souza","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4377-9742","authenticated-orcid":false,"given":"Binod","family":"Dhakal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nirav N.","family":"Shah","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5372-510X","authenticated-orcid":false,"given":"Mehdi","family":"Hamadani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jtct.2023.12.011_bib0001","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1016\/j.jtct.2021.09.016","article-title":"State of the CAR-T: risk of infections with chimeric antigen receptor T cell therapy and determinants of SARS-CoV-2 vaccine responses","volume":"27","author":"Meir","year":"2021","journal-title":"Transplant Cell Ther"},{"key":"10.1016\/j.jtct.2023.12.011_bib0002","doi-asserted-by":"crossref","first-page":"153","DOI":"10.56875\/2589-0646.1049","article-title":"Infectious complications and preventative strategies following chimeric antigen receptor T-cells (CAR-T cells) therapy for B-cell malignancies","volume":"15","author":"Haroon","year":"2022","journal-title":"Hematol Oncol Stem Cell Ther"},{"key":"10.1016\/j.jtct.2023.12.011_bib0003","doi-asserted-by":"crossref","first-page":"3585","DOI":"10.1038\/s41375-021-01466-0","volume":"35","author":"Spanjaart","year":"2021","journal-title":"Leukemia"},{"key":"10.1016\/j.jtct.2023.12.011_bib0004","doi-asserted-by":"crossref","first-page":"2427","DOI":"10.1182\/bloodadvances.2021005616","article-title":"COVID-19 and CAR T cells: a report on current challenges and future directions from the EPICOVIDEHA survey by EHA-IDWP","volume":"6","author":"Busca","year":"2022","journal-title":"Blood Adv"},{"key":"10.1016\/j.jtct.2023.12.011_bib0005","unstructured":"Johns Hopkins University of Medicine. Coronavirus Resource Center. Mortality analyses. Available at: https:\/\/coronavirus.jhu.edu\/data\/mortality. Accessed May 24, 2023."},{"key":"10.1016\/j.jtct.2023.12.011_bib0006","doi-asserted-by":"crossref","first-page":"e185","DOI":"10.1016\/S2352-3026(20)30429-4","article-title":"Clinical characteristics and outcomes of COVID-19 in haematopoietic stem-cell transplantation recipients: an observational cohort study","volume":"8","author":"Sharma","year":"2021","journal-title":"Lancet Haematol"},{"key":"10.1016\/j.jtct.2023.12.011_bib0007","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1016\/j.ccell.2022.01.010","article-title":"Immune response to three doses of mRNA SARS-CoV-2 vaccines in CD19-targeted chimeric antigen receptor T cell immunotherapy recipients","volume":"40","author":"Sesques","year":"2022","journal-title":"Cancer Cell"},{"key":"10.1016\/j.jtct.2023.12.011_bib0008","doi-asserted-by":"crossref","first-page":"1278","DOI":"10.1182\/blood.2021012769","article-title":"Response to SARS-CoV-2 vaccination in patients after hematopoietic cell transplantation and CAR-T cell therapy","volume":"138","author":"Dhakal","year":"2021","journal-title":"Blood"},{"key":"10.1016\/j.jtct.2023.12.011_bib0009","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1016\/j.ccell.2021.07.012","article-title":"Antibody response to SARS-CoV-2 vaccines in patients with hematologic malignancies","volume":"39","author":"Greenberger","year":"2021","journal-title":"Cancer Cell"},{"key":"10.1016\/j.jtct.2023.12.011_bib0010","doi-asserted-by":"crossref","first-page":"1529","DOI":"10.1001\/jamaoncol.2020.2367","article-title":"Coronavirus disease 2019 (COVID-19) and immune-engaging cancer treatment","volume":"6","author":"Abid","year":"2020","journal-title":"JAMA Oncol"},{"key":"10.1016\/j.jtct.2023.12.011_bib0011","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1016\/j.jtct.2021.06.024","article-title":"Safety and immunogenicity of the BNT162b2 mRNA COVID-19 vaccine in patients after allogeneic HCT or CD19-based CART therapy-a single-center prospective cohort study","volume":"27","author":"Ram","year":"2021","journal-title":"Transplant Cell Ther"},{"key":"10.1016\/j.jtct.2023.12.011_bib0012","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1002\/hon.2957","article-title":"SARS-CoV-2 vaccine response in CAR T-cell therapy recipients: a systematic review and preliminary observations","volume":"40","author":"Abid","year":"2022","journal-title":"Hematol Oncol"},{"key":"10.1016\/j.jtct.2023.12.011_bib0013","doi-asserted-by":"crossref","first-page":"1727","DOI":"10.1038\/s41409-022-01795-3","article-title":"Efficacy of SARS-CoV-2 primary and booster vaccine doses in CAR-T recipients - targeting the target antigen","volume":"57","author":"Uyemura","year":"2022","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.jtct.2023.12.011_bib0014","unstructured":"American Society of Hematology. ASH-ASTCT COVID-19 vaccination for HCT and CAR T cell recipients. Available at: https:\/\/www.hematology.org\/covid-19\/ash-astct-covid-19-vaccination-for-hct-and-car-t-cell-recipients. Accessed May 24, 2023."},{"key":"10.1016\/j.jtct.2023.12.011_bib0015","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1182\/blood.2019004000","article-title":"How I prevent infections in patients receiving CD19-targeted chimeric antigen receptor T cells for B-cell malignancies","volume":"136","author":"Hill","year":"2020","journal-title":"Blood"},{"key":"10.1016\/j.jtct.2023.12.011_bib0016","unstructured":"Centers for Disease Control and Prevention. Current COVID-19 Advisory Committee on Immunization Practices (ACIP) vaccine recommendations. Available at: https:\/\/www.cdc.gov\/vaccines\/covid-19\/clinical-considerations\/interim-considerations-us.html#table-01. Accessed May 24, 2023."},{"key":"10.1016\/j.jtct.2023.12.011_bib0017","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1016\/j.ccell.2022.02.010","article-title":"Efficacy of a third SARS-CoV-2 mRNA vaccine dose among hematopoietic cell transplantation, CAR T cell, and BiTE recipients","volume":"40","author":"Abid","year":"2022","journal-title":"Cancer Cell"},{"key":"10.1016\/j.jtct.2023.12.011_bib0018","doi-asserted-by":"crossref","DOI":"10.1128\/JCM.02257-20","article-title":"Comparative performance of five commercially available serologic assays to detect antibodies to SARS-CoV-2 and identify individuals with high neutralizing titers","volume":"59","author":"Patel","year":"2021","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.jtct.2023.12.011_bib0019","doi-asserted-by":"crossref","DOI":"10.1128\/JCM.00989-21","article-title":"Anti-SARS-CoV-2 antibody levels measured by the AdviseDx SARS-CoV-2 assay are concordant with previously available serologic assays but are not fully predictive of sterilizing immunity","volume":"59","author":"Bradley","year":"2021","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.jtct.2023.12.011_bib0020","doi-asserted-by":"crossref","first-page":"1849","DOI":"10.1182\/bloodadvances.2022008338","article-title":"Humoral and cellular responses to SARS-CoV-2 vaccines before and after chimeric antigen receptor\u2013modified T-cell therapy","volume":"7","author":"Gonzalez","year":"2023","journal-title":"Blood Adv"},{"key":"10.1016\/j.jtct.2023.12.011_bib0021","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1016\/j.bbmt.2018.12.758","article-title":"ASTCT Consensus Grading for cytokine release syndrome and neurologic toxicity associated with immune effector cells","volume":"25","author":"Lee","year":"2019","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.jtct.2023.12.011_bib0022","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/S1470-2045(21)00695-1","article-title":"Early immunomodulators with CAR T-cell immunotherapy in the COVID-19 era","volume":"23","author":"Abid","year":"2022","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.jtct.2023.12.011_bib0023","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1016\/S0140-6736(23)00872-3","article-title":"The denominator in early phase CAR T-cell trials examining novel target antigens","volume":"402","author":"Abid","year":"2023","journal-title":"Lancet"},{"key":"10.1016\/j.jtct.2023.12.011_bib0024","doi-asserted-by":"crossref","first-page":"3186","DOI":"10.3324\/haematol.2023.283003","article-title":"Protracted viral infections in patients with multiple myeloma receiving bispecific T-cell engager therapy targeting B-cell maturation antigen","volume":"108","author":"Palmen","year":"2023","journal-title":"Haematologica"},{"key":"10.1016\/j.jtct.2023.12.011_bib0025","doi-asserted-by":"crossref","first-page":"398.e1","DOI":"10.1016\/j.jtct.2023.03.005","article-title":"Severe acute respiratory syndrome coronavirus 2 vaccine immunogenicity among chimeric antigen receptor T cell therapy recipients","volume":"29","author":"Aleissa","year":"2023","journal-title":"Transplant Cell Ther"},{"key":"10.1016\/j.jtct.2023.12.011_bib0026","doi-asserted-by":"crossref","first-page":"2066","DOI":"10.1182\/bloodadvances.2022007806","article-title":"Cellular and humoral immune responses to SARS-CoV-2 vaccination in patients after CD19.CAR T-cell therapy","volume":"7","author":"Reimann","year":"2023","journal-title":"Blood Adv"},{"key":"10.1016\/j.jtct.2023.12.011_bib0027","doi-asserted-by":"crossref","first-page":"1280","DOI":"10.1038\/s41591-021-01386-7","article-title":"CD8+ T cells contribute to survival in patients with COVID-19 and hematologic cancer","volume":"27","author":"Bange","year":"2021","journal-title":"Nat Med"},{"key":"10.1016\/j.jtct.2023.12.011_bib0028","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1038\/s41591-022-01700-x","article-title":"Ancestral SARS-CoV-2-specific T cells cross-recognize the Omicron variant","volume":"28","author":"Gao","year":"2022","journal-title":"Nat Med"},{"key":"10.1016\/j.jtct.2023.12.011_bib0029","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1001\/jamaoncol.2021.6030","article-title":"SARS-CoV-2 spike-specific T-cell responses in patients with B-cell depletion who received chimeric antigen receptor T-cell treatments","volume":"8","author":"Parvathaneni","year":"2022","journal-title":"JAMA Oncol"},{"key":"10.1016\/j.jtct.2023.12.011_bib0030","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1056\/NEJMc2119358","article-title":"Third BNT162b2 vaccination neutralization of SARS-CoV-2 Omicron infection","volume":"386","author":"Nemet","year":"2022","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jtct.2023.12.011_bib0031","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/j.ccell.2021.12.014","article-title":"COVID-19 mRNA booster vaccines elicit strong protection against SARS-CoV-2 Omicron variant in patients with cancer","volume":"40","author":"Zeng","year":"2022","journal-title":"Cancer Cell"}],"container-title":["Transplantation and Cellular Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666636723017463?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666636723017463?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,13]],"date-time":"2025-11-13T03:12:00Z","timestamp":1763003520000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2666636723017463"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,3]]},"references-count":31,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2024,3]]}},"alternative-id":["S2666636723017463"],"URL":"https:\/\/doi.org\/10.1016\/j.jtct.2023.12.011","relation":{},"ISSN":["2666-6367"],"issn-type":[{"value":"2666-6367","type":"print"}],"subject":[],"published":{"date-parts":[[2024,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Efficacy of Multiple SARS-CoV-2 Vaccine Doses in Patients with B Cell Hematologic Malignancies Receiving Chimeric Antigen Receptor T Cell Therapy: A Contemporary Cohort Analysis","name":"articletitle","label":"Article Title"},{"value":"Transplantation and Cellular Therapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jtct.2023.12.011","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The American Society for Transplantation and Cellular Therapy. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}